Essais liés3clinical trials
VilleBucharestlocalisation
PaysRomanialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06540833

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
ITI-1284 Alzheimer Phase 2 NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia RECRUITING
ITI-1284 Alzheimer Phase 2 NCT06540833 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease RECRUITING
Ponesimod SEP Phase 3 NCT03232073 Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis COMPLETED